SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '9ZJ'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2NNH_A_9CRA501_1 (CYTOCHROME P450 2C8) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 5 / 11 | ARG A 98GLY A 99ILE A 114ALA A 298THR A 302 | HEM A 501 (-2.8A)None9ZJ A 502 ( 3.6A)9ZJ A 502 ( 3.5A)9ZJ A 502 ( 3.9A) | 0.76A | 2nnhA-5wbgA:51.7 | 2nnhA-5wbgA:61.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2NNH_A_9CRA501_1 (CYTOCHROME P450 2C8) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 6 / 11 | ARG A 98ILE A 114ALA A 298THR A 302VAL A 367PRO A 368 | HEM A 501 (-2.8A)9ZJ A 502 ( 3.6A)9ZJ A 502 ( 3.5A)9ZJ A 502 ( 3.9A)9ZJ A 502 ( 4.2A)None | 0.64A | 2nnhA-5wbgA:51.7 | 2nnhA-5wbgA:61.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2NNH_B_9CRB501_1 (CYTOCHROME P450 2C8) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 5 / 9 | ARG A 98ILE A 114THR A 302VAL A 367PRO A 368 | HEM A 501 (-2.8A)9ZJ A 502 ( 3.6A)9ZJ A 502 ( 3.9A)9ZJ A 502 ( 4.2A)None | 0.53A | 2nnhB-5wbgA:44.6 | 2nnhB-5wbgA:61.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2NNJ_A_225A501_1 (CYTOCHROME P450 2C8) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 5 / 10 | ILE A 114ALA A 298THR A 302VAL A 367PRO A 368 | 9ZJ A 502 ( 3.6A)9ZJ A 502 ( 3.5A)9ZJ A 502 ( 3.9A)9ZJ A 502 ( 4.2A)None | 0.65A | 2nnjA-5wbgA:52.5 | 2nnjA-5wbgA:61.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3E4E_A_4PZA501_1 (CYTOCHROME P450 2E1) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 3 / 3 | ALA A 298THR A 302CYH A 436 | 9ZJ A 502 ( 3.5A)9ZJ A 502 ( 3.9A)HEM A 501 (-2.0A) | 0.39A | 3e4eA-5wbgA:54.8 | 3e4eA-5wbgA:56.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3E4E_B_4PZB501_1 (CYTOCHROME P450 2E1) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 3 / 3 | ALA A 298THR A 302CYH A 436 | 9ZJ A 502 ( 3.5A)9ZJ A 502 ( 3.9A)HEM A 501 (-2.0A) | 0.32A | 3e4eB-5wbgA:54.8 | 3e4eB-5wbgA:56.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3KW4_A_TICA600_1 (CYTOCHROME P450 2B4) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 7 / 11 | ILE A 114ILE A 209SER A 210ALA A 298VAL A 367VAL A 477GLY A 478 | 9ZJ A 502 ( 3.6A)9ZJ A 502 ( 4.8A)None9ZJ A 502 ( 3.5A)9ZJ A 502 ( 4.2A)NoneNone | 0.77A | 3kw4A-5wbgA:58.4 | 3kw4A-5wbgA:86.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3KW4_A_TICA600_1 (CYTOCHROME P450 2B4) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 7 / 11 | ILE A 114ILE A 209SER A 210THR A 302VAL A 367VAL A 477GLY A 478 | 9ZJ A 502 ( 3.6A)9ZJ A 502 ( 4.8A)None9ZJ A 502 ( 3.9A)9ZJ A 502 ( 4.2A)NoneNone | 0.85A | 3kw4A-5wbgA:58.4 | 3kw4A-5wbgA:86.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ME6_A_CGEA501_1 (CYTOCHROME P450 2B4) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 9 / 10 | VAL A 104PHE A 108PHE A 206ILE A 209PHE A 297ALA A 298THR A 302VAL A 367VAL A 477 | None9ZJ A 502 (-4.4A)9ZJ A 502 (-2.6A)9ZJ A 502 ( 4.8A)9ZJ A 502 ( 4.5A)9ZJ A 502 ( 3.5A)9ZJ A 502 ( 3.9A)9ZJ A 502 ( 4.2A)None | 0.54A | 3me6A-5wbgA:59.1 | 3me6A-5wbgA:86.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ME6_A_CGEA501_1 (CYTOCHROME P450 2B4) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 7 / 10 | VAL A 104PHE A 115PHE A 206ILE A 209PHE A 297ALA A 298THR A 302 | None9ZJ A 502 (-4.7A)9ZJ A 502 (-2.6A)9ZJ A 502 ( 4.8A)9ZJ A 502 ( 4.5A)9ZJ A 502 ( 3.5A)9ZJ A 502 ( 3.9A) | 1.46A | 3me6A-5wbgA:59.1 | 3me6A-5wbgA:86.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ME6_B_CGEB501_1 (CYTOCHROME P450 2B4) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 8 / 8 | PHE A 108PHE A 206ILE A 209PHE A 297ALA A 298THR A 302VAL A 367VAL A 477 | 9ZJ A 502 (-4.4A)9ZJ A 502 (-2.6A)9ZJ A 502 ( 4.8A)9ZJ A 502 ( 4.5A)9ZJ A 502 ( 3.5A)9ZJ A 502 ( 3.9A)9ZJ A 502 ( 4.2A)None | 0.66A | 3me6B-5wbgA:59.3 | 3me6B-5wbgA:86.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ME6_B_CGEB501_1 (CYTOCHROME P450 2B4) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 5 / 8 | PHE A 115PHE A 206ILE A 209PHE A 297ALA A 298 | 9ZJ A 502 (-4.7A)9ZJ A 502 (-2.6A)9ZJ A 502 ( 4.8A)9ZJ A 502 ( 4.5A)9ZJ A 502 ( 3.5A) | 1.19A | 3me6B-5wbgA:59.3 | 3me6B-5wbgA:86.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ME6_C_CGEC501_1 (CYTOCHROME P450 2B4) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 9 / 9 | VAL A 104PHE A 108PHE A 206ILE A 209PHE A 297ALA A 298THR A 302VAL A 367VAL A 477 | None9ZJ A 502 (-4.4A)9ZJ A 502 (-2.6A)9ZJ A 502 ( 4.8A)9ZJ A 502 ( 4.5A)9ZJ A 502 ( 3.5A)9ZJ A 502 ( 3.9A)9ZJ A 502 ( 4.2A)None | 0.46A | 3me6C-5wbgA:59.1 | 3me6C-5wbgA:86.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ME6_C_CGEC501_1 (CYTOCHROME P450 2B4) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 7 / 9 | VAL A 104PHE A 115PHE A 206ILE A 209PHE A 297ALA A 298THR A 302 | None9ZJ A 502 (-4.7A)9ZJ A 502 (-2.6A)9ZJ A 502 ( 4.8A)9ZJ A 502 ( 4.5A)9ZJ A 502 ( 3.5A)9ZJ A 502 ( 3.9A) | 1.42A | 3me6C-5wbgA:59.1 | 3me6C-5wbgA:86.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ME6_D_CGED501_1 (CYTOCHROME P450 2B4) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 9 / 9 | VAL A 104PHE A 108PHE A 206ILE A 209PHE A 297ALA A 298THR A 302VAL A 367VAL A 477 | None9ZJ A 502 (-4.4A)9ZJ A 502 (-2.6A)9ZJ A 502 ( 4.8A)9ZJ A 502 ( 4.5A)9ZJ A 502 ( 3.5A)9ZJ A 502 ( 3.9A)9ZJ A 502 ( 4.2A)None | 0.62A | 3me6D-5wbgA:59.1 | 3me6D-5wbgA:86.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ME6_D_CGED501_1 (CYTOCHROME P450 2B4) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 7 / 9 | VAL A 104PHE A 115PHE A 206ILE A 209PHE A 297ALA A 298THR A 302 | None9ZJ A 502 (-4.7A)9ZJ A 502 (-2.6A)9ZJ A 502 ( 4.8A)9ZJ A 502 ( 4.5A)9ZJ A 502 ( 3.5A)9ZJ A 502 ( 3.9A) | 1.47A | 3me6D-5wbgA:59.1 | 3me6D-5wbgA:86.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3Q_A_9PLA501_1 (CYTOCHROME P450 2A6) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 5 / 10 | PHE A 108PHE A 115PHE A 297ALA A 298THR A 302 | 9ZJ A 502 (-4.4A)9ZJ A 502 (-4.7A)9ZJ A 502 ( 4.5A)9ZJ A 502 ( 3.5A)9ZJ A 502 ( 3.9A) | 0.53A | 3t3qA-5wbgA:56.5 | 3t3qA-5wbgA:66.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3Q_B_9PLB501_1 (CYTOCHROME P450 2A6) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 5 / 10 | PHE A 108PHE A 115PHE A 297ALA A 298THR A 302 | 9ZJ A 502 (-4.4A)9ZJ A 502 (-4.7A)9ZJ A 502 ( 4.5A)9ZJ A 502 ( 3.5A)9ZJ A 502 ( 3.9A) | 0.51A | 3t3qB-5wbgA:56.4 | 3t3qB-5wbgA:66.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3Q_C_9PLC501_1 (CYTOCHROME P450 2A6) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 5 / 10 | PHE A 108PHE A 115PHE A 297ALA A 298THR A 302 | 9ZJ A 502 (-4.4A)9ZJ A 502 (-4.7A)9ZJ A 502 ( 4.5A)9ZJ A 502 ( 3.5A)9ZJ A 502 ( 3.9A) | 0.51A | 3t3qC-5wbgA:56.4 | 3t3qC-5wbgA:66.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3Q_D_9PLD501_1 (CYTOCHROME P450 2A6) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 5 / 10 | PHE A 108PHE A 115PHE A 297ALA A 298THR A 302 | 9ZJ A 502 (-4.4A)9ZJ A 502 (-4.7A)9ZJ A 502 ( 4.5A)9ZJ A 502 ( 3.5A)9ZJ A 502 ( 3.9A) | 0.54A | 3t3qD-5wbgA:56.6 | 3t3qD-5wbgA:66.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3R_D_9PLD501_1 (CYTOCHROME P450 2A6) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 5 / 10 | PHE A 107PHE A 108PHE A 202ASN A 242ILE A 241 | None9ZJ A 502 (-4.4A)NoneNoneNone | 1.34A | 3t3rD-5wbgA:55.6 | 3t3rD-5wbgA:66.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3S_A_9PLA1_1 (CYTOCHROME P450 2A13) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 5 / 9 | PHE A 108PHE A 206PHE A 297ALA A 298THR A 302 | 9ZJ A 502 (-4.4A)9ZJ A 502 (-2.6A)9ZJ A 502 ( 4.5A)9ZJ A 502 ( 3.5A)9ZJ A 502 ( 3.9A) | 0.71A | 3t3sA-5wbgA:56.2 | 3t3sA-5wbgA:65.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3S_A_9PLA1_1 (CYTOCHROME P450 2A13) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 5 / 9 | PHE A 115PHE A 206PHE A 297ALA A 298THR A 302 | 9ZJ A 502 (-4.7A)9ZJ A 502 (-2.6A)9ZJ A 502 ( 4.5A)9ZJ A 502 ( 3.5A)9ZJ A 502 ( 3.9A) | 1.29A | 3t3sA-5wbgA:56.2 | 3t3sA-5wbgA:65.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3S_B_9PLB1_1 (CYTOCHROME P450 2A13) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 4 / 6 | PHE A 108PHE A 297ALA A 298THR A 302 | 9ZJ A 502 (-4.4A)9ZJ A 502 ( 4.5A)9ZJ A 502 ( 3.5A)9ZJ A 502 ( 3.9A) | 0.41A | 3t3sB-5wbgA:56.0 | 3t3sB-5wbgA:65.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3S_C_9PLC1_1 (CYTOCHROME P450 2A13) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 4 / 7 | PHE A 297ALA A 298THR A 302LEU A 363 | 9ZJ A 502 ( 4.5A)9ZJ A 502 ( 3.5A)9ZJ A 502 ( 3.9A)HEM A 501 (-4.3A) | 0.47A | 3t3sC-5wbgA:55.8 | 3t3sC-5wbgA:65.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3S_E_9PLE1_1 (CYTOCHROME P450 2A13) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 4 / 8 | PHE A 108PHE A 297ALA A 298THR A 302 | 9ZJ A 502 (-4.4A)9ZJ A 502 ( 4.5A)9ZJ A 502 ( 3.5A)9ZJ A 502 ( 3.9A) | 0.25A | 3t3sE-5wbgA:54.9 | 3t3sE-5wbgA:65.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3Z_C_9PLC501_1 (CYTOCHROME P450 2E1) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 4 / 5 | PHE A 108PHE A 297ALA A 298THR A 302 | 9ZJ A 502 (-4.4A)9ZJ A 502 ( 4.5A)9ZJ A 502 ( 3.5A)9ZJ A 502 ( 3.9A) | 1.15A | 3t3zC-5wbgA:54.4 | 3t3zC-5wbgA:56.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TMZ_A_06XA503_1 (CYTOCHROME P450 2B4) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 6 / 11 | ILE A 101ILE A 114ILE A 209ALA A 298VAL A 367PRO A 368 | 9ZJ A 502 (-4.5A)9ZJ A 502 ( 3.6A)9ZJ A 502 ( 4.8A)9ZJ A 502 ( 3.5A)9ZJ A 502 ( 4.2A)None | 0.92A | 3tmzA-5wbgA:55.7 | 3tmzA-5wbgA:86.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TMZ_A_06XA503_1 (CYTOCHROME P450 2B4) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 6 / 11 | ILE A 101ILE A 114ILE A 209THR A 302VAL A 367PRO A 368 | 9ZJ A 502 (-4.5A)9ZJ A 502 ( 3.6A)9ZJ A 502 ( 4.8A)9ZJ A 502 ( 3.9A)9ZJ A 502 ( 4.2A)None | 0.99A | 3tmzA-5wbgA:55.7 | 3tmzA-5wbgA:86.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TMZ_A_06XA503_1 (CYTOCHROME P450 2B4) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 5 / 11 | ILE A 114ALA A 298VAL A 367PRO A 368VAL A 477 | 9ZJ A 502 ( 3.6A)9ZJ A 502 ( 3.5A)9ZJ A 502 ( 4.2A)NoneNone | 0.86A | 3tmzA-5wbgA:55.7 | 3tmzA-5wbgA:86.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TMZ_A_06XA503_1 (CYTOCHROME P450 2B4) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 5 / 11 | ILE A 114THR A 302VAL A 367PRO A 368VAL A 477 | 9ZJ A 502 ( 3.6A)9ZJ A 502 ( 3.9A)9ZJ A 502 ( 4.2A)NoneNone | 0.83A | 3tmzA-5wbgA:55.7 | 3tmzA-5wbgA:86.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TMZ_A_06XA504_1 (CYTOCHROME P450 2B4) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 5 / 9 | ILE A 101ILE A 209GLN A 215GLU A 218GLU A 387 | 9ZJ A 502 (-4.5A)9ZJ A 502 ( 4.8A)NoneNoneNone | 0.90A | 3tmzA-5wbgA:55.7 | 3tmzA-5wbgA:86.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TMZ_A_06XA504_1 (CYTOCHROME P450 2B4) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 5 / 9 | LEU A 52ILE A 101ILE A 209GLN A 215GLU A 218 | None9ZJ A 502 (-4.5A)9ZJ A 502 ( 4.8A)NoneNone | 1.17A | 3tmzA-5wbgA:55.7 | 3tmzA-5wbgA:86.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TMZ_A_06XA504_1 (CYTOCHROME P450 2B4) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 5 / 9 | LEU A 70ILE A 101ILE A 209GLN A 215GLU A 387 | None9ZJ A 502 (-4.5A)9ZJ A 502 ( 4.8A)NoneNone | 0.86A | 3tmzA-5wbgA:55.7 | 3tmzA-5wbgA:86.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UA5_B_06XB501_1 (CYTOCHROME P450 2B6) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 4 / 7 | ILE A 114THR A 302LEU A 363VAL A 477 | 9ZJ A 502 ( 3.6A)9ZJ A 502 ( 3.9A)HEM A 501 (-4.3A)None | 0.66A | 3ua5B-5wbgA:54.8 | 3ua5B-5wbgA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EJG_A_NCTA501_1 (CYTOCHROME P450 2A13) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 4 / 7 | PHE A 115PHE A 297ALA A 298THR A 302 | 9ZJ A 502 (-4.7A)9ZJ A 502 ( 4.5A)9ZJ A 502 ( 3.5A)9ZJ A 502 ( 3.9A) | 0.41A | 4ejgA-5wbgA:56.5 | 4ejgA-5wbgA:65.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EJG_B_NCTB501_1 (CYTOCHROME P450 2A13) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 5 / 8 | PHE A 115PHE A 297ALA A 298THR A 302LEU A 363 | 9ZJ A 502 (-4.7A)9ZJ A 502 ( 4.5A)9ZJ A 502 ( 3.5A)9ZJ A 502 ( 3.9A)HEM A 501 (-4.3A) | 0.60A | 4ejgB-5wbgA:56.4 | 4ejgB-5wbgA:65.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EJG_C_NCTC501_1 (CYTOCHROME P450 2A13) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 4 / 7 | PHE A 108PHE A 115ALA A 298LEU A 363 | 9ZJ A 502 (-4.4A)9ZJ A 502 (-4.7A)9ZJ A 502 ( 3.5A)HEM A 501 (-4.3A) | 0.46A | 4ejgC-5wbgA:56.5 | 4ejgC-5wbgA:65.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EJG_D_NCTD501_1 (CYTOCHROME P450 2A13) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 4 / 6 | PHE A 115ALA A 298THR A 302LEU A 363 | 9ZJ A 502 (-4.7A)9ZJ A 502 ( 3.5A)9ZJ A 502 ( 3.9A)HEM A 501 (-4.3A) | 0.44A | 4ejgD-5wbgA:56.4 | 4ejgD-5wbgA:65.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4H1N_A_CGEA505_1 (CYTOCHROME P450 2B4) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 8 / 11 | ILE A 101ILE A 114ILE A 209LEU A 238ALA A 298THR A 302VAL A 367VAL A 477 | 9ZJ A 502 (-4.5A)9ZJ A 502 ( 3.6A)9ZJ A 502 ( 4.8A)None9ZJ A 502 ( 3.5A)9ZJ A 502 ( 3.9A)9ZJ A 502 ( 4.2A)None | 0.73A | 4h1nA-5wbgA:58.0 | 4h1nA-5wbgA:86.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4JLT_A_8PRA505_1 (CYTOCHROME P450 2B4) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 6 / 8 | ILE A 101ILE A 114GLU A 218ALA A 298VAL A 367PRO A 368 | 9ZJ A 502 (-4.5A)9ZJ A 502 ( 3.6A)None9ZJ A 502 ( 3.5A)9ZJ A 502 ( 4.2A)None | 0.70A | 4jltA-5wbgA:57.9 | 4jltA-5wbgA:86.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AY4_A_TPFA506_1 (CYP51, STEROL14ALPHA-DEMETHYLASE) |
5wbg | CYTOCHROME P450 2B6 (Homosapiens) | 5 / 10 | PHE A 297ALA A 298THR A 302LEU A 363CYH A 436 | 9ZJ A 502 ( 4.5A)9ZJ A 502 ( 3.5A)9ZJ A 502 ( 3.9A)HEM A 501 (-4.3A)HEM A 501 (-2.0A) | 0.76A | 6ay4A-5wbgA:31.7 | 6ay4A-5wbgA:14.25 |